Microfluidic single-cell analysis of cancer exosomes

癌症外泌体的微流控单细胞分析

基本信息

  • 批准号:
    8883617
  • 负责人:
  • 金额:
    $ 18.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

Most eukaryotic cells secrete numerous membrane-derived vesicles of 30-150 nm in size termed exosomes. As an emerging mechanism for cell-to-cell communication, exosomes have been recently found to play important roles in a wide range of biological processes, including cancer development and metastasis. For instance, increasing evidences support the cancer-derived exosomes can reprogram the behavior of recipient cells to promote tumor growth and metastasis. Despite the significance of exosomes, our understanding of their biogenesis, molecular classification, and biological functions remain very limited. One of the challenges is to analyze exosomes released from single cells. Because cells in a tumor are known to be remarkably heterogeneous, single-cell analysis of exosomes is crucial to understanding their pathological roles in cancer. However, current “gold standard” methods can only perform ensemble measurements of exosomes released from a large cell population because of their poor isolation yield, insufficient analysis sensitivity and low throughput. In this proposal, the PI aims to develop for the first time a high-throughput single cell exosome analysis system (SCEAS) capable of probing the secretion and molecular composition of exosomes at the single cell level. The goal will be achieved via two specific aims: 1) develop a microfluidic exosome barcode chip for multiplexed, ultrasensitive immunofluorescence detection of exosomes; and 2) develop and validate a Single Cell Exosome Analysis System (SCEAS) for quantitative phenotyping of exosomes derived from single cancer cells. Success of the work will yield a key tool to enable the studies of heterogeneous exosome release by tumor cells at the single cell level, which would facilitate better understanding of intercellular signaling pathways underlying cancer development, metastasis, and drug resistance.
大多数真核细胞分泌许多大小为30-150 nm的膜衍生囊泡,称为外泌体。作为一种新兴的细胞间通讯机制,外泌体最近被发现在广泛的生物学过程中发挥重要作用,包括癌症的发展和转移。例如,越来越多的证据支持癌症来源的外泌体可以重新编程受体细胞的行为以促进肿瘤生长和转移。尽管外泌体具有重要意义,但我们对其生物起源,分子分类和生物学功能的了解仍然非常有限。挑战之一是分析从单细胞释放的外泌体。由于已知肿瘤中的细胞具有显著的异质性,因此外泌体的单细胞分析对于了解它们在癌症中的病理作用至关重要。然而,目前的“金标准”方法只能对从大细胞群体释放的外泌体进行整体测量,因为它们的分离产率差、分析灵敏度不足和通量低。在这项提案中,PI旨在首次开发一种高通量单细胞外泌体分析系统(SCEAS),能够在单细胞水平上探测外泌体的分泌和分子组成。该目标将通过两个具体目标实现:1)开发用于外泌体的多重、超灵敏免疫荧光检测的微流体外泌体条形码芯片;以及2)开发和验证用于来源于单个癌细胞的外泌体的定量表型的单细胞外泌体分析系统(SCEAS)。这项工作的成功将产生一个关键的工具,使肿瘤细胞在单细胞水平上异质外泌体释放的研究成为可能,这将有助于更好地理解癌症发展、转移和耐药性背后的细胞间信号通路。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yong Zeng其他文献

Yong Zeng的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yong Zeng', 18)}}的其他基金

Integrated Digital Microfluidic Platforms for Next-Generation Glycomics
用于下一代糖组学的集成数字微流控平台
  • 批准号:
    9167059
  • 财政年份:
    2016
  • 资助金额:
    $ 18.32万
  • 项目类别:
Integrated Digital Microfluidic Platforms for Next-Generation Glycomics
用于下一代糖组学的集成数字微流控平台
  • 批准号:
    9323361
  • 财政年份:
    2016
  • 资助金额:
    $ 18.32万
  • 项目类别:
Microfluidic single-cell analysis of cancer exosomes
癌症外泌体的微流控单细胞分析
  • 批准号:
    9119174
  • 财政年份:
    2016
  • 资助金额:
    $ 18.32万
  • 项目类别:
Integrated Microfluidic Exosome Profiling for Early Detection of Cancer
用于癌症早期检测的集成微流控外泌体分析
  • 批准号:
    9114066
  • 财政年份:
    2014
  • 资助金额:
    $ 18.32万
  • 项目类别:
Integrated Microfluidic Exosome Profiling for Early Detection of Cancer
用于癌症早期检测的集成微流控外泌体分析
  • 批准号:
    8739059
  • 财政年份:
    2014
  • 资助金额:
    $ 18.32万
  • 项目类别:
Multiplexed Profiling of Single-Cell Secreted Exosomes
单细胞分泌的外泌体的多重分析
  • 批准号:
    9360660
  • 财政年份:
  • 资助金额:
    $ 18.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了